AMBER KELLY: Open Payments
NPI 1871975847 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,525 in 95 payments from 18 companies in 2025. Trend: 2023 $2,090 · 2024 $1,622 · 2025 $1,525
Food & beverage: $1,525
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 22 | $287 |
| Merck Sharp & Dohme LLC | 10 | $232 |
| Amgen Inc. | 22 | $161 |
| Novartis Pharmaceuticals Corporation | 7 | $131 |
| Abbott Laboratories | 2 | $129 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $97 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $79 |
| Philips North America LLC | 4 | $72 |
| PFIZER INC. | 3 | $54 |
| E.R. Squibb & Sons, L.L.C. | 3 | $50 |
Products named: JARDIANCE, VERQUVO, REPATHA, LEQVIO, AVEIR, LifeVest, ELIQUIS, Kerendia.
Industry payments across LA — which companies pay providers there.
